Yahoo Finance Billionaire-Tracking ETF Just Bulked Up On Health Care
Investing in some of the world’s top hedge funds may not be feasible for the majority of investors, yet that doesn’t mean they can’t participate in many of their best ideas.
The Direxion iBillionaire Index ETF (NYSE: IBLN) is one example of an ETF that seeks to harvest the top holdings from a select group of billionaire investors. These famed strategists are required to report their largest positions on SEC Form 13F filings -- publicly-available information from which an index can be constructed.
IBLN selects 30 large-cap stocks from a pool of up to 10 billionaires and equal weights them across its portfolio. According to the fund company's website, “IBLN is designed to help long term-investors pursue a better portfolio outcome by seeking excess returns relative to the S&P 500 Index.”
Related Link: 7 Reasons Warren Buffett Should Run For President
The latest IBLN rebalancing led to some interesting changes across the spectrum of holdings that reduced exposure to technology companies and bulked up on health care names.
This ETF dropped the following stocks:
Chesapeake Energy Corporation (NYSE: CHK) - Energy
EMC Corporation (NYSE: EMC) - Technology
Facebook Inc (NASDAQ: FB) - Technology
PVH Corp (NYSE: PVH) – Consumer Discretionary
Yahoo! Inc. (NASDAQ: YHOO) - Technology
It subsequently added the following new positions:
American Airlines Group Inc (NYSE: AAL) - Industrials
Applied Materials, Inc. (NASDAQ: AMAT) - Technology
DirecTV (NASDAQ: DTV) – Consumer Discretionary
Endo International (NASDAQ: ENDP) – Health Care
Humana Inc (NYSE: HUM) – Health Care
McKesson Corporation (NYSE: MCK) – Health Care
After rebalancing, the portfolio continues to be heavily weighted toward consumer discretionary stocks at 30 percent. In addition, health care companies now make up 23 percent of the total assets and energy has been reduced to just a single stock at 3 percent.
On a year-to-date basis, IBLN has gained 1.65 percent in total return versus 4.20 percent in the SPDR S&P 500 ETF (NYSE: SPY).
It’s natural to assume that an ETF such as IBLN will undergo periods of outperformance and underperformance based on its concentrated portfolio and strategic positioning.
See more from Benzinga
© 2015 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.